Raphael Pharmaceutical annual return on equity
2021
2022
2023
Raphael Pharmaceutical Return on Equity (ROE) Growth & History (RAPH)
Raphael Pharmaceutical's return on equity was −1,261.97% for fiscal 2023.
View full Raphael Pharmaceutical company overviewRaphael Pharmaceutical annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | −1,261.97% | +1608.11 pp |
| 2022 | 2022-12-31 | −2,870.09% | +953.44 pp |
| 2021 | 2021-12-31 | −3,823.53% | — |
Raphael Pharmaceutical quarterly return on equity
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q4.23
Q1.24
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q1 2024 | 2024-03-31 | −27,500.00% | −26955.67 pp |
| Q4 2023 | 2023-12-31 | 387.50% | +5401.14 pp |
| Q1 2023 | 2023-03-31 | −544.33% | −384.16 pp |
| Q4 2022 | 2022-12-31 | −5,013.64% | +32786.36 pp |
| Q3 2022 | 2022-09-30 | −5,153.57% | — |
| Q2 2022 | 2022-06-30 | −567.42% | — |
| Q1 2022 | 2022-03-31 | −160.17% | — |
| Q4 2021 | 2021-12-31 | −37,800.00% | — |
Raphael Pharmaceutical return on equity trends
Between the periods ended 2021-12-31 and 2023-12-31, Raphael Pharmaceutical's return on equity increased from −3,823.53% to −1,261.97%, a change of +2561.56 percentage points. The latest reported quarter, Q1 2024, shows −27,500.00%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Raphael Pharmaceutical source filings ↗